November 19, 2025

BeGraft Plus for BEVAR — Now CE-Approved.

Certificates

English (International)

With the CE approval of BeGraft Plus for use as a bridging stent graft in branched endovascular aneurysm repair (BEVAR), Bentley is expanding its portfolio for complex aortic interventions. The extended length range of up to 78 mm now provides physicians with an on-label solution for the BeGraft Plus that allows bridging longer distances in challenging anatomies.

The BeGraft Plus Stent Graft System is indicated for permanent intraluminal placement in the iliac and renal arteries to restore or improve vessel patency, and to seal aneurysms, acute perforations, ruptures, and fistulas. Furthermore, the BeGraft Plus Stent Graft System is indicated for use as a bridging stent graft in patients requiring endovascular abdominal aortic aneurysm repair with a branched aortic endovascular graft to keep the visceral arteries perfused.

In BEVAR, preserving blood flow to the visceral arteries while achieving stable apposition requires a stent graft that combines high radial strength, reliable sealing performance, and high conformability. BeGraft Plus is engineered to support this balance — particularly in cases where the bridging segment is not supported by the native anatomy and must maintain stability on its own

Sebastian Büchert

CEO of Bentley

We developed BeGraft Plus in close collaboration with physicians who were looking for a bridging solution that offers stability, controlled deployment, and precision in complex cases. With this CE approval, we reinforce our role as a trusted partner in complex endovascular repair. BeGraft Plus provides radial support with the flexibility physicians need in challenging anatomy. It’s a solution shaped by clinical practice and made for confidence in the most demanding procedures.

Engineered for confidence in complex repair

BeGraft Plus features a unique stent-in-stent design that provides strong fixation and secure sealing. The extended length options allow bridging longer distances without additional extension, which may reduce procedural complexity and the risk of reinterventions.

Key characteristics include:

High radial force to support vessel patency in demanding anatomies
Secure sealing performance supported by unique stent-in-stent design
Exceptional kink resistance while maintaining lateral flexibility

Dr. Martin Austermann

Vascular Surgeon at St. Franziskus Hospital, Assistant Professor of Vascular Surgery at the University of Münster, Germany, and coordinating investigator of the clinical BEVAR study.

In branched aortic repair, how a device behaves in real anatomy is critical. BeGraft Plus provides the radial support needed for stable apposition, along with the flexibility to accommodate patient-specific anatomy. The initial clinical experience is encouraging, and having an on-label option for use as a bridging stent in BEVAR procedures offers physicians an important additional choice in complex aortic repair.

The BeGraft Plus Stent Graft System with the BEVAR indication is CE-marked and now available in markets where local regulatory clearance has been granted. First clinical cases under the new indication are expected in the coming weeks.

Bentley will present the expanded BeGraft Plus portfolio at the PVI Congress in Paris this December, followed by a broader introduction at LINC 2026 in Leipzig, Germany.

Head of Corporate Communications

Nadja Atwaa